US$ 29.58
peptide science klow Stack Research Overview KLOW Blend: Advanced Peptide Therapy
Description
The combination of CJC-1295 No DAC and Ipamorelin continues to receive interest within peptide-focused research settings and analytical laboratory environments

Fragment (176191) is a modified C-terminal fragment of human growth hormone, while CJC-1295 (No DAC) is a growth hormonereleasing hormone (GHRH) analog and Ipamorelin is a selective growth hormone secretagogue receptor (GHS-R) agonist

Fabriqu en France

Game-changer!" - David K

Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) is listed on Core Peptide USA as part of our peptide blend catalog